Alkyl Amines Chemicals Limited's Board of Directors, at its meeting held on May 5, 2026 (commencing at 12:30 PM and concluding at 1:50 PM), approved the audited financial results for the quarter and financial year ended March 31, 2026. The board also recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval at the ensuing Annual General Meeting. The results were reviewed and recommended by the Audit Committee at its meeting held on the same date. Statutory auditor M/s. N. M. Raiji & Co., Chartered Accountants, Mumbai (Registration No. 108296W), represented by Partner Vinay D. Balse (Membership No. 039434), issued an unmodified audit opinion on the financial results.

Q4 FY26 and Full-Year Financial Performance

The company reported revenue from operations of ₹386.91 crores for Q4 FY26, marginally higher than ₹386.05 crores in Q4 FY25 and up from ₹354.00 crores in Q3 FY26. For the full year FY26, revenue from operations stood at ₹1,535.85 crores compared to ₹1,571.82 crores in FY25. The following table summarises the key financial metrics:

Expense Breakdown

Total expenses for Q4 FY26 stood at ₹334.40 crores against ₹336.02 crores in Q4 FY25, reflecting a marginal improvement. For the full year FY26, total expenses were ₹1,324.04 crores compared to ₹1,352.98 crores in FY25. Key expense components for the quarter and full year are presented below:

Balance Sheet Highlights

As at March 31, 2026, total assets stood at ₹1,895.41 crores, up from ₹1,788.85 crores as at March 31, 2025. Total equity increased to ₹1,533.37 crores from ₹1,402.49 crores. Cash and cash equivalents at year-end were ₹94.15 crores, compared to ₹48.78 crores at the beginning of the year. Capital Work-in-Progress rose significantly to ₹130.48 crores from ₹51.91 crores, indicating ongoing capital investment activity. Key balance sheet figures are as follows:

Cash Flow Summary

For FY26, net cash from operating activities was ₹238.55 crores against ₹263.10 crores in FY25. Cash used in investing activities was ₹137.09 crores, primarily driven by purchase of property, plant and equipment including capital work-in-progress of ₹128.41 crores and investment in mutual funds of ₹50.00 crores. Cash used in financing activities was ₹56.09 crores, which included dividend paid of ₹51.15 crores.

Dividend and Other Key Disclosures

The Board has recommended a final dividend of ₹10 per equity share of ₹2 each (500%) for FY26, subject to shareholder approval. The trading window for designated persons, their immediate relatives, and connected persons will open from May 8, 2026, following the announcement of audited financial results. The company operates within a single operating segment — Specialty Chemicals — as per IND AS 108. It has no subsidiary, associate, or joint venture entity for FY26 or FY25, and accordingly the results are standalone. The company also restructured employee compensation effective March 1, 2026, in line with the four Labour Codes notified by the Government of India on November 21, 2025; the financial impact, based on actuarial valuation, was assessed as not material. The results were signed by Yogesh M. Kothari, Chairman & Managing Director, and authorized by Chintamani D. Thatte, General Manager (Legal) & Company Secretary & Compliance Officer.

Alkyl Amines Chemicals Limited has officially announced the gradual restart of its ammonia-based product manufacturing operations through a regulatory filing to stock exchanges. The company informed BSE and NSE about the resumption of production activities following improvements in the global ammonia supply situation.

Official Communication and Regulatory Filing

The company submitted its business update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was signed by Chintamani Thatte, General Manager (Legal) & Company Secretary & Compliance Officer, and addressed to both major Indian stock exchanges.

Background of Supply Chain Disruptions

The production restart follows the company's earlier disclosure dated March 16, 2026, which highlighted the impact of ongoing geopolitical conflicts in the Middle East. These conflicts had caused substantial disruptions across multiple sectors including logistics networks, global supply chains for crude oil, petrochemicals, and ammonia availability across international markets.

Current Supply Situation and Production Strategy

According to the official filing, while the overall ammonia supply situation continues to remain uncertain and dynamic, conditions have improved sufficiently to enable a gradual restart of ammonia-based product manufacturing.

Strategic Approach to Recovery

The gradual restart approach demonstrates the company's cautious but optimistic stance toward market recovery. This phased resumption strategy reflects prudent risk management while capitalizing on improving supply chain conditions. The restart represents a positive development for the company's operational capacity and its ability to serve customer demands that were affected during the supply chain disruption period.

The company's proactive communication strategy, providing timely updates on both initial disruptions and subsequent recovery, maintains transparency with stakeholders regarding material developments affecting operations and production capabilities.